Search

Search Results
Results 82431 - 82440 of 82452 for cancer
  • 11th Tumour Models London Summit
    Supplier - 6 Oct 2022
    Celebrate 11 Years of Tumour Models With Us this December!  The preclinical and translational landscape has vastly evolved over the past 11 years. There have been exciting breakthroughs in novel...
  • PARP & DDR Inhibitors Summit 2020
    Supplier - 23 Jan 2020
    The PARP & DDR Inhibitors Summit 2020 gathers the VPs, Heads and Directors of Translational Oncology, Target Discovery, and Early Drug Development.
  • Quanterix
    Supplier - 31 Jul 2019
    Quanterix is on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease.
  • Menarini Silicon Biosystems
    Supplier - 3 Jul 2018
    Menarini Silicon Biosystems S.p.A. manufactures and markets health care technologies and products. The Company offers products and solutions for isolation, recovery, and analysis of intact and...
  • TeraView Ltd.
    Supplier - 6 Feb 2017
    TeraView is the world’s first and leading company solely focused upon the application of terahertz light to provide solutions to customer issues.
  • Integrated DNA Technologies
    Supplier - 11 Dec 2015
    IDT manufactures the oligo using chemical DNA synthesis machines designed and built in-house. They've refined the process to the point where they can receive an order as late as 1:00pm and have the...
  • Daylight Solutions Inc
    Supplier - 15 Apr 2015
    Daylight Solutions was founded in January, 2005 by three high tech entrepreneurs. Today the company consists of 60 people who share a vision of developing and advancing breakthrough technologies and...
  • Scientifica
    Supplier - 21 Nov 2023
    Who Are We? We support researchers in achieving breakthroughs in neuroscience, cardiology, cancer, and various scientific fields by supplying cutting-edge electrophysiology, multiphoton imaging, and...
  • Targeting Protein Misfolding Congress 2021
    Supplier - 7 Dec 2020
    With the neurological drug market now worth $86 billion, and the FDA set to reach a decision on Biogen’s Acudanimib in Spring, whether you’re focused on oncology, Alzheimer’s or ALS, it’s an exciting...
  • 5th Oncolytic Virotherapy Summit
    Supplier - 24 Sep 2019
    The Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback